Six CYSL Steering Committee members share insights on the alliance's mission to empower young Chinese liver researchers worldwide through mentorship and global collaboration.
The inaugural CYSL Annual Meeting in Barcelona brought together top journal editors and young Chinese researchers for a day of scientific exchange and mentorship.
CYSL Starlight Corridor podcast features Dr. Yee Hui Yeo from Cedars-Sinai Medical Center, sharing his Best Abstract award-winning research on personalised DPMAS treatment in liver failure.
A large Swedish cohort study finds GLP-1 RAs associated with reduced risk of liver decompensation and HCC in patients with chronic liver disease and type 2 diabetes. — Gut
Nationwide study reveals excess mortality in MASLD driven by liver-related deaths, extrahepatic cancers, and cardiovascular disease, especially in advanced fibrosis. — J Hepatol
Type-1/2/3 inflammatory signatures stratify severity in acutely decompensated cirrhosis, enabling precision immunophenotyping for targeted management. — J Hepatol
Sequential FIB-4 + LSM screening pathway efficiently detects advanced fibrosis in type 2 diabetes, reducing unnecessary referrals while maintaining accuracy. — Gut